1. 17P-Estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women;Christiansen, C.; Riis, B.J.;J ClGn EndocrinolMetab,1991
2. The use of transdermal estrogen treatment in osteoporosis;Lufkin, E.G.; Hodgson, S.F.; Kotowicz, M.A.; O'Fallon, W.M.; Wahner, H.W.; Riggs, B.L.,1990
3. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis;Storm, T.; Thamsborg, G.; Steiniche, T.; Genant, H.K.; S0rensen, O.H.;N Engl J7 Med,1990
4. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis;Watts, N.B.; Harris, S.T.; Genant, H.K.; Wasnich, R.D.; Miller, P.D.; Jackson, R.D.;N Englj Med,1990
5. Long-term calcitonin therapy in postmenopausal osteoporosis;Gruber, H.E.; Ivey, J.L.; Baylink, D.J.; Matthews, M.; Nelp, W.B.; Sisom, K.;Metabolism,1984